Insights into the role of Erysipelotrichaceae in the human host

Frontiers in Cellular and Infection Microbiology

Volumn 5, Issue NOV, 2015, Pages

  Kaakoush, Nadeem O ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Colorectal cancer; Erysipelotrichaceae; Gastrointestinal; Inflammatory bowel diseases; Metabolic disorders; Microbiota

Indexed keywords

IMMUNOGLOBULIN A; QUERCETIN; TUMOR NECROSIS FACTOR ALPHA;

DIGESTIVE SYSTEM INFLAMMATION; ERYSIPELOTRICHACEAE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INTESTINE FLORA; LIPID DIET; LIPID METABOLISM; METABOLIC DISORDER; NONHUMAN; NOTE; SUPPLEMENTATION; WESTERN DIET; ANIMAL; FIRMICUTES; GASTROINTESTINAL DISEASE; MICROBIOLOGY; OBESITY; PHYSIOLOGY;

ANIMALS; FIRMICUTES; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; OBESITY;

EID: 85006217723     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2015.00084     Document Type: Note

References (29)

1. Agouridis, A. P., Elisaf, M., and Milionis, H. J. (2011). An overview of lipid abnormalities in patients with inflammatory bowel disease. Ann. Gastroenterol. 24, 181-187.
2. Chen, W., Liu, F., Ling, Z., Tong, X., and Xiang, C. (2012). Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE 7:e39743. doi: 10.1371/journal.pone.0039743
3. Craven, M., Egan, C. E., Dowd, S. E., McDonough, S. P., Dogan, B., Denkers, E. Y., et al. (2012). Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease. PLoS ONE 7:e41594. doi: 10.1371/journal.pone.0041594
4. Dey, N., Soergel, D. A., Repo, S., and Brenner, S. E. (2013). Association of gut microbiota with post-operative clinical course in Crohn's disease. BMC Gastroenterol. 13:131. doi: 10.1186/1471-230X-13-131
5. Dinh, D. M., Volpe, G. E., Duffalo, C., Bhalchandra, S., Tai, A. K., Kane, A. V., et al. (2015). Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J. Infect. Dis. 211, 19-27. doi: 10.1093/infdis/jiu409
6. Etxeberria, U., Arias, N., Boqué, N., Macarulla, M. T., Portillo, M. P., Martínez, J. A., et al. (2015). Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats. J. Nutr. Biochem. 26, 651-660. doi: 10.1016/j.jnutbio.2015.01.002
7. Fleissner, C. K., Huebel, N., Abd El-Bary, M. M., Loh, G., Klaus, S., and Blaut, M. (2010). Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 104, 919-929. doi: 10.1017/S0007114510001303
8. Gassull, M. A., Fernández-Bañares, F., Cabré, E., Papo, M., Giaffer, M. H., Sánchez-Lombraña, J. L., et al. (2002). Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 51, 164-168.
9. Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., et al. (2014). The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382-392. doi: 10.1016/j.chom.2014.02.005
10. Harris, J. K., El Kasmi, K. C., Anderson, A. L., Devereaux, M. W., Fillon, S. A., Robertson, C. E., et al. (2014). Specific microbiome changes in a mouse model of parenteral nutrition associated liver injury and intestinal inflammation. PLoS ONE 9:e110396. doi: 10.1371/journal.pone.0110396
11. Hurt, R. T., and Wilson, T. (2012). Geriatric obesity: evaluating the evidence for the use of flavonoids to promote weight loss. J. Nutr. Gerontol. Geriatr. 31, 269-289. doi: 10.1080/21551197.2012.698222
12. Kaakoush, N. O., Day, A. S., Leach, S. T., Lemberg, D. A., Nielsen, S., and Mitchell, H. M. (2015). Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn's disease. Clin. Transl. Gastroenterol. 6, e71. doi: 10.1038/ctg.2014.21
13. Kwok, A. H., Li, Y., Jiang, J., Jiang, P., and Leung, F. C. (2014). Complete genome assembly and characterization of an outbreak strain of the causative agent of swine erysipelas-Erysipelothrix rhusiopathiae SY1027. BMC Microbiol. 14:176. doi: 10.1186/1471-2180-14-176
14. Labbé, A., Ganopolsky, J. G., Martoni, C. J., Prakash, S., and Jones, M. L. (2014). Bacterial bile metabolising gene abundance in Crohn's, ulcerative colitis and type 2 diabetes metagenomes. PLoS ONE 9:e115175. doi: 10.1371/journal.pone.0115175
15. Li, Y., Zhu, W., Gong, J., Zuo, L., Zhang, W., Gu, L., et al. (2014). Influence of exclusive enteral nutrition therapy on visceral fat in patients with Crohn's disease. Inflamm. Bowel Dis. 20, 1568-1574. doi: 10.1097/MIB.0000000000000114
16. Martínez, I., Perdicaro, D. J., Brown, A. W., Hammons, S., Carden, T. J., Carr, T. P., et al. (2013). Diet-induced alterations of host cholesterol metabolism are likely to affect the gut microbiota composition in hamsters. Appl. Environ. Microbiol. 79, 516-524. doi: 10.1128/AEM.03046-12
17. Martínez, I., Wallace, G., Zhang, C., Legge, R., Benson, A. K., Carr, T. P., et al. (2009). Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Appl. Environ. Microbiol. 75, 4175-4184. doi: 10.1128/AEM.00380-09
18. Nahidi, L., Leach, S. T., Mitchell, H. M., Kaakoush, N. O., Lemberg, D. A., Munday, J. S., et al. (2013). Inflammatory bowel disease therapies and gut function in a colitis mouse model. Biomed. Res. Int. 2013:909613. doi: 10.1155/2013/909613
19. Nguyen, T. L., Vieira-Silva, S., Liston, A., and Raes, J. (2015). How informative is the mouse for human gut microbiota research? Dis. Model Mech. 8, 1-16. doi: 10.1242/dmm.017400
20. Palm, N. W., de Zoete, M. R., Cullen, T. W., Barry, N. A., Stefanowski, J., Hao, L., et al. (2014). Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158, 1000-1010. doi: 10.1016/j.cell.2014.08.006
21. Parmentier-Decrucq, E., Duhamel, A., Ernst, O., Fermont, C., Louvet, A., Vernier-Massouille, G., et al. (2009). Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease. Inflamm. Bowel Dis. 15, 1476-1484. doi: 10.1002/ibd.20931
22. Schaubeck, M., Clavel, T., Calasan, J., Lagkouvardos, I., Haange, S. B., Jehmlich, N., et al. (2015). Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence. Gut. doi: 10.1136/gutjnl-2015-309333. [Epub ahead of print].
23. Spencer, M. D., Hamp, T. J., Reid, R. W., Fischer, L. M., Zeisel, S. H., and Fodor, A. A. (2011). Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 140, 976-986. doi: 10.1053/j.gastro.2010.11.049
24. Turnbaugh, P. J., Bäckhed, F., Fulton, L., and Gordon, J. I. (2008). Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223. doi: 10.1016/j.chom.2008.02.015
25. Zhang, C., Zhang, M., Wang, S., Han, R., Cao, Y., Hua, W., et al. (2010). Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 4, 232-241. doi: 10.1038/ismej.2009.112
26. Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., et al. (2009). Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. U.S.A. 106, 2365-2370. doi: 10.1073/pnas.0812600106
27. Zhao, Y., Wu, J., Li, J. V., Zhou, N. Y., Tang, H., and Wang, Y. (2013). Gut microbiota composition modifies fecal metabolic profiles in mice. J. Proteome Res. 12, 2987-2999. doi: 10.1021/pr400263n
28. Zhu, Q., Jin, Z., Wu, W., Gao, R., Guo, B., Gao, Z., et al. (2014). Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS ONE 9:e90849. doi: 10.1371/journal.pone.0090849
29. Zschaler, J., Schlorke, D., and Arnhold, J. (2014). Differences in innate immune response between man and mouse. Crit. Rev. Immunol. 34, 433-454. doi: 10.1615/critrevimmunol.2014011600